Joanne M. Donovan

2.2k citations

48 papers · 1.7k indexed · h-index 22

Surgery top 5%
Molecular Biology
Endocrinology, Diabetes and Metabolism top 5%
Oncology top 10%
Cancer Research top 10%

Co-authors: Martin C. Carey Steven K. Burke David Q.‐H. Wang Erik Eckhardt George B. Benedek Michael H. Davidson Phillip D. Toth Robert Dufour
Topics: Drug Transport and Resistance Mechanisms (16 papers)Lipoproteins and Cardiovascular Health (12 papers)Muscle Physiology and Disorders (11 papers)
Cited by: Endocrinology, Diabetes and Metabolism Surgery Cancer Research
Journals: Proceedings of the National Academy of Sciences Circulation Blood
Partner nations: United States United Kingdom Canada

In The Last Decade

Joanne M. Donovan

47 papers receiving 1.6k citations

Peers

Countries citing papers authored by Joanne M. Donovan

Since Specialization

Citations

This map shows the geographic impact of Joanne M. Donovan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne M. Donovan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne M. Donovan more than expected).

Fields of papers citing papers by Joanne M. Donovan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne M. Donovan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne M. Donovan. The network helps show where Joanne M. Donovan may publish in the future.

Co-authorship network of co-authors of Joanne M. Donovan

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne M. Donovan. A scholar is included among the top collaborators of Joanne M. Donovan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne M. Donovan. Joanne M. Donovan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Mixed-Method Study Exploring Patient-Experienced and Caregiver-Reported Benefits and Side Effects of Corticosteroid Use in Duchenne Muscular Dystrophy 2023 ·Journal of Neuromuscular Diseases ·Ryan Fischer,Katherine Ackerman Porter,Joanne M. Donovan,Mena Scavina,(unknown),(unknown),(unknown),Holly L. Peay	3
2	Edasalonexent, an NF-kB Inhibitor, Slows Longer-Term Disease Progression on Multiple Functional and MRI Assessments Compared to Control Period in 4 to 7-Year Old Patients with Duchenne Muscular Dystrophy (S51.006) 2019 ·Neurology ·Richard S. Finkel,Krista Vandenborne,H. Lee Sweeney,Erika Finanger,Gihan Tennekoon,Perry B. Shieh,(unknown),Glenn A. Walter,William D. Rooney,Sean C. Forbes,William Triplett,Sabrina W. Yum,Maria Mancini,James E. MacDougall,(unknown),Pradeep Bista,Andrew J. Nichols,Joanne M. Donovan	2
3	Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry 2019 ·BMC Neurology ·(unknown),Maria Mancini,Ann Martin,Ann Lucas,Joanne M. Donovan	33
4	Move DMD Results: Effects of Edasalonexent, an NF-kB Inhibitor, in 4 to 7 Year Old Patients with Duchenne Muscular Dystrophy (P3.210) 2017 ·Neurology ·Joanne M. Donovan,Krista Vandenborne,(unknown),Gihan Tennekoon,Erika Finanger,Sabrina W. Yum,Perry B. Shieh,Maria Mancini,Pradeep Bista,Andrew J. Nichols,Richard S. Finkel	1
5	Proceedings of a Parent Project Muscular Dystrophy Bone Health Workshop 2017 ·Neuromuscular Disorders ·Leanne M. Ward,Kathi Kinnett,Lynda F. Bonewald,Jonathan D. Adachi,Laura K. Bachrach,Teresita Bellido,Marco Brotto,Joanne M. Donovan,Eric P. Hoffman,Mary B. Leonard,Hugh J. McMillan,Susan A. Novotny,Jill A. Rafael‐Fortney,Frank Rauch,Stuart J. Warden	6
6	PHASE 1 SINGLE AND MULTIPLE ASCENDING DOSE STUDY OF CAT-2003, A NOVEL ACTIVATOR OF LIPOPROTEIN LIPASE, DEMONSTRATES REDUCTIONS IN POSTPRANDIAL TRIGLYCERIDES 2014 ·Journal of the American College of Cardiology ·Joanne M. Donovan,Richard L. Dunbar,(unknown),Douglas Logan,Michael J. Curtis,Maria Mancini,Michael R. Jirousek	6
7	Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia 2014 ·Journal of clinical lipidology ·Raúl D. Santos,Frederick J. Raal,Joanne M. Donovan,William C. Cromwell	30
8	Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial 2012 ·European Heart Journal ·Maartje E. Visser,Gilbert Wagener,Brenda F. Baker,Richard S. Geary,Joanne M. Donovan,Ulrich Beuers,Aart J. Nederveen,Joanne Verheij,Mieke D. Trip,Dick C.G. Basart,John J.P. Kastelein,Erik S.G. Stroes	140
9	Long-Term Safety and Efficacy of Mipomersen in Patients with Familial Hypercholesterolemia Uncontrolled by Maximally Tolerated Lipid Lowering Therapy 2012 ·Journal of clinical lipidology ·P. Barton Duell,Raúl D. Santos,Cara East,John R. Guyton,Patrick M. Moriarty,Joanne M. Donovan,Robert S. Mittleman	8
10	A 50-Week Extension Study on the Safety and Efficacy of Colesevelam in Adults with Primary Hypercholesterolemia 2010 ·American Journal of Cardiovascular Drugs ·Michael H. Davidson,Joanne M. Donovan,Soamnauth Misir,Michael R. Jones	18
11	Abstract 19931: Mipomersen, An Apolipoprotein B Synthesis Inhibitor, Reduces Small LDL Particle Number and Increases LDL Particle Size in Patients with Heterozygous Familial Hypercholestrolemia and Coronary Artery Disease 2010 ·Circulation ·William C. Cromwell,Robert Dufour,Claude Gagné,Daniel Gaudet,Cara East,Joanne M. Donovan,Wai Chin,Diane L. Tribble,Mary P. McGowan	2
12	Low‐dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low‐density lipoprotein cholesterol in patients with primary hypercholesterolemia 2001 ·Clinical Cardiology ·Michael H. Davidson,Phillip D. Toth,Stuart Weiss,James M. McKenney,(unknown),Jonathan L. Isaacsohn,Joanne M. Donovan,Steven K. Burke	81
13	Effectiveness of Colesevelam Hydrochloride in Decreasing LDL Cholesterol in Patients With Primary Hypercholesterolemia: A 24-Week Randomized Controlled Trial 2001 ·Mayo Clinic Proceedings ·William Insull,Phillip D. Toth,William S. Mullican,Donald B. Hunninghake,Steven K. Burke,Joanne M. Donovan,Michael H. Davidson	109
14	Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia 2001 ·The American Journal of Medicine ·(unknown),Helmut G. Schrott,Patrick Ma,Robert H. Knopp,(unknown),J. Michael Gaziano,Joanne M. Donovan,Steven K. Burke,Michael Davidson	158
15	Drug Interactions with Colesevelam Hydrochloride, a Novel, Potent Lipid-Lowering Agent 2000 ·Cardiovascular Drugs and Therapy ·Joanne M. Donovan,Daria Stypinski,Mark R. Stiles,Timothy A. Olson,Steven K. Burke	70
16	PHYSICAL AND METABOLIC FACTORS IN GALLSTONE PATHOGENESIS 1999 ·Gastroenterology Clinics of North America ·Joanne M. Donovan	55
17	Colorectal Cancer in Women: An Underappreciated but Preventable Risk 1998 ·Journal of women's health ·Joanne M. Donovan,Sapna Syngal	33
18	Bile Acid/Phosphatidylcholine Interactions in Mixed Monomolecular Layers: Differences in Condensation Effects but not Interfacial Orientation between Hydrophobic and Hydrophilic Bile Acid Species 1995 ·Biochemistry ·(unknown),Martin C. Carey,Joanne M. Donovan	42
19	Calcium affinity for biliary lipid aggregates in model biles: Complementary importance of bile salts and lecithin 1994 ·Gastroenterology ·Joanne M. Donovan,Monika R. Leonard,Ashok K. Batta,Martin C. Carey	19
20	Pan-sulfation of bile salts markedly increases hydrophilicity and essentially abolishes self- and hetero-association with lecithin 1993 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Joanne M. Donovan,Ibrahim Yousef,Martin C. Carey	6

About Joanne M. Donovan

Joanne M. Donovan is a scholar working on Oncology, Genetics and Surgery, having authored 48 papers that have together received 1.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (16 papers), Lipoproteins and Cardiovascular Health (12 papers) and Muscle Physiology and Disorders (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (430 citations), Surgery (821 citations) and Cancer Research (205 citations). Joanne M. Donovan has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Martin C. Carey, Steven K. Burke, David Q.‐H. Wang, Erik Eckhardt, George B. Benedek, Michael H. Davidson, Phillip D. Toth, Robert Dufour, Diane L. Tribble and Claude Gagné. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact